Business and technology support for companies, investors and scientific institutions in Berlin – this is the Berlin Partner für Wirtschaft und Technologie GmbH mission. With customized services and an excellent science and research network, our many experts provide an outstanding range of programs to help companies launch, innovate, expand and secure their economic future in Berlin.
BIO Deutschland is the sector association of the German biotechnology industry and has set itself the objective of supporting and promoting the development of an innovative economic sector based on modern biosciences. The Berlin-based association currently has over 330 members. It is run by a board of ten members consisting of CEOs and managing directors of biotechnology companies. Using a wide range of political initiatives, BIO Deutschland lobbies for improvements to the legal parameters for innovative small and medium-sized enterprises. BIO Deutschland represents Germany’s biotechnology sector at the Federation of German Industries (BDI), at the European association (EuropaBio) in Brussels and at the US-American BIO in Washington. The association is also very active in a broad range of events with the aim of providing biotechnology with a platform for discussion and interaction.
BioAlps is a non-profit organization fostering and promoting the excellence and performance of life sciences sector of Western Switzerland worldwide.
BioAlps is the world most diversified life science cluster and one of the most dynamic.
It hosts more than 1250 companies, 33 academic institutions, 62 support and coaching organisms, 500 public and private laboratories, 17 scientific parks, incubators and technology transfer bodies active all in the life science representing more than 37'500 people and 5000 researchers.
With a mission of promoting the excellence and performance in Life Sciences developments in this cluster at all levels: regionally, nationally and in the international arena, BioAlps is the entry point to a wealth of contacts, know-how, knowledge and provides both personal and institutional support.
BioPartner is an independent, government-accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's delegations promote the UK presence at major international biopharma conferences, and companies are assisted with access to government grants and heavily discounted entry fees. Through the BioPartner Programme, members receive extra benefits and support to effectively trade overseas.
Biopôle Lausanne is an innovation-oriented life sciences campus hosting a vibrant community of industry players and research institutes, based in Lausanne at the heart of the "Health Valley", Switzerland's largest life sciences cluster. Biopôle Lausanne provides 134,000 sqm/1,442,000 sqft of laboratory and office space, added value services, a life sciences incubator StartLab, a hub dedicated to Digital Health, living space and community engagement where members can thrive and bring science to life. We host 90+ companies & organisations, incl. multinationals, innovative start-ups & SMEs, together with technology & service providers. It also hosts 25 world-famous research groups from the Lausanne University Hospital (CHUV), University of Lausanne (UNIL) and the Ludwig Institute for Cancer Research. Founded in 2004 by the canton of Vaud, Biopôle SA is a privately held not-for-profit company that is responsible for the management and promotion of the campus. www.biopole.ch
Biotechgate is the global Business Development Database for the Biotech, Pharma and Medtech industries with over 55,000 companies listed. Search for innovative biotech and pharma assets as well as medical devices. Identify relevant companies, clinical trials, management details and financing rounds. Powered by a unique data sourcing process. www.biotechgate.com
citigate dewe rogerson
Citigate Dewe Rogerson is one of the world's leading strategic communications consultancies.
Our Life Sciences team has established a reputation for excellence spanning financial, corporate and scientific communications; this has enabled us to become trusted advisors and to build a broad portfolio including some of the most innovative and exciting international life sciences companies. Our clients are at all stages of development, from start-up to multinationals, and our activities are focused on delivering campaigns that support corporate objectives. As a result, we have been involved in major corporate transactions and events in the life sciences sector over the past decade such as IPOs, other public and private fundraisings, and M&As.
Recent IPO transactions: ABIVAX (Euronext Paris - €60m), OSE Pharma (Euronext Paris - €21m), Nordic Nanovector (Oslo – NOK575m), Midatech Pharma (London AIM - £32m), Abzena (London AIM - £20m), arGEN-X (Brussels - €42m), Pixium Vision (Euronext Paris - €39.5m), Crossject (Euronext Paris - €17m). Other recent financings: Abingworth (£225m ABV VI), Rigontec (€14.25m Series A), Calcivis (£4.5m fundraising), ViraTherapeutics ($3.6m - Series A). Recent M&A: Heptares (up to $400m acquisition by Sosei), Prosonix (up to £100m acquisition by Circassia), bioquell (Sale of subsidiary for £44.5m).
FreeMind is a consulting group whose goal is to assist in maximizing potential to receive funding from non-dilutive sources. Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. FreeMind's proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date.
Our expertise in applying for grants and contracts extends throughout every government mechanism open to funding the life sciences including all NIH institutes, DoD, NSF, FDA, CDC, BARDA, etc., as well as private foundations. FreeMind's knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our team of experts will assist in making non-dilutive funding a key tool in a long-term financial strategy.
Innovaud is the innovation agency for the canton of Vaud, in Switzerland’s Lake Geneva region. Innovaud helps tech-oriented companies (startups, scale-ups, SMEs and corporates) develop their businesses and carry out innovation projects. It also assists foreign companies wanting to set up in the canton of Vaud. In 2020 Innovaud merged with Vaud's economic development agency (DEV) to create a single point of contact and offer a more comprehensive array of services.
Instinctif Partners is an international business communications consultancy. With a track record of delivering truly creative programmes, the Life Sciences practice focuses on enhancing the value proposition for companies seeking investment, partnerships or customers. Our core skill is working with clients to communicate the value of their science and innovation to key stakeholders through the most relevant channels: crafting communications solutions that showcase each company, product or technology. Specifically, we are unique in offering specialist expertise seamlessly across corporate, financial, healthcare and marketing communications with outreach programmes to media, industry, professional, public, financial and investment communities. Our service offering covers all communications disciplines including strategic counsel, PR, IR, media relations, public affairs, crisis communications, internal communications, marketing, advertising, copywriting, design, research and event management. Our globally integrated and dedicated life sciences team serves clients around the world from our headquarters in London, and bases across Europe, AsiaPac and the USA. https://instinctif.com/eu/
PLATTFORM LIFE SCIENCES
The Life Sciences-Series - Launched in 2014 four issues of the Life Sciences-Series appear annually. Based on the three pillars – technology, financing, investment – the issues combine current topics of life sciences with knowledge and networking from corporate financing and capital market. The mission: Building a cross medial bridge between the life sciences and the financial industry by the help of the quarterly Life Sciences issues, the monthly digital newsletter LifeSciencesUpdate
Schwarz Financial Communication is a boutique investor relations and corporate communications consulting with a focus on innovative companies in the life sciences sector. With over 20 years of capital market experience it advises and supports companies in the conception and implementation of communication tools that are geared towards banks, investors, analysts and the media. Simultaneously, we secure the arrival of these messages to the accurate recipient by means of our established financial community network.
Schwarz Financial Communication works with companies that feel driven to actively communicate and engage with their shareholders. The international customer base is made up equally of small and medium-sized companies. Our quality communication consulting is strongly determined by entrepreneurial commitment, the right skills, experience and creativity.
The Swiss Private Equity & Corporate Finance Association (SECA) is the representative body for Switzerland‘s private equity, venture capital and corporate finance industries. SECA has the objective to promote private equity and corporate finance activities in Switzerland. Members of the SECA include equity investment companies, banks, corporate finance advisors, auditing companies, management consultants, lawyers and private investors.
Swiss Biotech unites the four leading biotech regions of Switzerland (BioAlps, BaselArea, Biopolo Ticino and Greater Zurich Area). The regions have early on combined efforts with the SWX Swiss Exchange which holds a leading position in terms of life-science listings and services.
The National Industry Association named Swiss Biotech Association Represents more than 150 companies to date and acts as the operational arm for the marketing alliance. Swiss Biotech raises Switzerland’s profile as an economic center in Europe and profiles the biotech industry with its key research institutions and companies.Swiss Biotechs’ mission is to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of the drivers of biotechnology including research, education, economics, finance and industry. The bases for success in biotechnology are the critical mass of research institutes and accelerated technology transfer. The early integration of industry and well-trained workforce is another critical success factor for rapid economic growth. More than 40 technology parks throughout the country support the increasingly important and successful TechTransfer process.
Tiberend Strategic Advisors, Inc. is a corporate communications firm providing media strategy and execution for life science companies – biotech (therapeutics), medical devices and diagnostics. We work with both public and private emerging growth companies: 1. To enhance valuation 2. To build visibility for partnerships and strategic alliances